These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1285281)

  • 1. Structure-function relations in schizophrenia: brain morphology and neuropsychology.
    Bilder RM
    Prog Exp Pers Psychopathol Res; 1992; 15():183-251. PubMed ID: 1285281
    [No Abstract]   [Full Text] [Related]  

  • 2. Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients.
    Curzon G; Kantamaneni BD; Van Boxel P; Gillman PK; Bartlett JR; Bridges PK
    Acta Psychiatr Scand Suppl; 1980; 280():3-20. PubMed ID: 6157303
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine therapy and increases in homovanillic acid.
    Risch SC
    Arch Gen Psychiatry; 1995 Mar; 52(3):244. PubMed ID: 7532936
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurotransmitters and neuropeptides in schizophrenia].
    Toru M; Ichikawa H
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1838-54. PubMed ID: 6085408
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia.
    Ohlund LS; Lindström LH; Ohman A
    J Nerv Ment Dis; 1992 May; 180(5):304-13. PubMed ID: 1374792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 7. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

  • 8. Low cerebrospinal fluid homovanillic acid-5-hydroxyindoleacetic acid ratio predicts clozapine efficacy: a replication.
    Risch SC; Lewine RR
    Arch Gen Psychiatry; 1993 Aug; 50(8):670. PubMed ID: 7688212
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibited depressions, clinical and spinal fluid findings].
    Roccatagliata G; Albano C; Bartolini A
    Riv Neurol; 1982; 52(4):212-7. PubMed ID: 6182600
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
    Losonczy MF; Song IS; Mohs RC; Mathé AA; Davidson M; Davis BM; Davis KL
    Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin in violent patients with schizophrenia.
    Kunz M; Sikora J; Krakowski M; Convit A; Cooper TB; Volavka J
    Psychiatry Res; 1995 Nov; 59(1-2):161-3. PubMed ID: 8771232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of neurotransmitters in psychiatric pathology].
    Gherardi D; Fabrizio E; Chirillo S; Garzia P
    Minerva Psichiatr; 1992; 33(4):247-58. PubMed ID: 1284315
    [No Abstract]   [Full Text] [Related]  

  • 14. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoamine metabolite levels in cerebrospinal fluid of schizophrenic patients].
    Imazu Y; Kobayashi K; Kawabata M; Shohmori T
    Seishin Shinkeigaku Zasshi; 1985; 87(9):634-42. PubMed ID: 2419935
    [No Abstract]   [Full Text] [Related]  

  • 18. Course of illness and predictors of outcome in chronic schizophrenia: implications for pathophysiology.
    Breier A; Schreiber JL; Dyer J; Pickar D
    Br J Psychiatry Suppl; 1992 Oct; (18):38-43. PubMed ID: 1389040
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
    Takahashi S; Kondo H; Kato N
    J Psychiatr Res; 1975 Nov; 12(3):177-87. PubMed ID: 1081591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.